Defining the mechanism of action of 4-phenylbutyrate to develop a small-molecule-based therapy for Alzheimer's disease.
4-phenylbutyrate (PBA) is a small molecule that restores cognitive deficits in animal models of Alzheimer's disease (AD). Although the molecular basis of the cognitive benefits of PBA remains unknown, a multi-modal/multi-target mechanism has been proposed. Putative targets of this drug are diff...
| Hlavní autoři: | , , , , |
|---|---|
| Médium: | info:eu-repo/semantics/article |
| Jazyk: | eng |
| Vydáno: |
Bentham Science Publ LTD
2012
|
| Témata: | |
| On-line přístup: | https://hdl.handle.net/10171/23299 |